INBX position history
The shares of Inhibrx Biosciences (INBX) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 1,787,705 shares, $25M, 0.10% of portfolio, New
- 2024 Q3: 1,787,705 shares, $28M, 0.10% of portfolio
- 2024 Q4: 1,787,705 shares, $28M, 0.09% of portfolio
- 2025 Q1: 1,787,705 shares, $25M, 0.08% of portfolio
- 2025 Q2: 1,787,705 shares, $26M, 0.07% of portfolio
- 2025 Q3: 1,787,705 shares, $60M, 0.16% of portfolio
- 2025 Q4: 1,437,705 shares, $114M, 0.30% of portfolio, Reduce −19.6%
- 2026 Q1: 1,437,705 shares, $97M, 0.27% of portfolio
- 2026 Q2: 1,123,929 shares, $106M, 0.30% of portfolio, Reduce −21.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|